Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Joanne Verheij is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for pancreatic cancer treatment, particularly through high-impact randomized controlled trials. Her major contributions center on establishing the oncological safety and efficacy of minimally invasive distal pancreatectomy (MIDP) compared to traditional open surgery for resectable pancreatic cancer. Dr. Verheij is the principal investigator of the landmark DIPLOMA trial, the first international randomized non-inferiority study to rigorously compare MIDP with open distal pancreatectomy for pancreatic ductal adenocarcinoma. This pivotal work, published in 2023 and already cited over 120 times, addresses critical concerns about the oncological safety of minimally invasive approaches in pancreatic cancer surgery. Her 2021 study protocol for the DIPLOMA trial, with nearly 40 citations, laid the groundwork for this investigation by outlining the methodology for evaluating time to functional recovery and long-term outcomes. Dr. Verheij’s research directly informs surgical decision-making, challenging traditional paradigms and potentially expanding the role of minimally invasive surgery in pancreatic cancer care. Her work is essential reading for surgeons and researchers interested in evidence-based surgical innovation and improving recovery for pancreatic cancer patients.